KAPA
Kairos Pharma, Ltd.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
Kairos Pharma, Ltd.
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
—
Expected move
No implied move.
No reported quarters.
No linked exposure.
No open-interest data.
0.54
0.00 · −0.20%
post 0.53 −1.67%
Bar = avg |move| to ±6% · tick = ±4.9% avg day · ×base = |move| ÷ ±4.9% · min 6 releases
| Quarter | Reported | EPS | Consensus |
|---|---|---|---|
| Q2 FY26 | — | -0.06 | — |
| Q1 FY26 | — | -0.08 | — |
Source: filed financials
−6.22%
shares held · 7 largest managers
No filed income statement.